Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 102 Neoplasm Metastasis 26 Neoplasms 15 Brain Neoplasms 13 Prostatic Neoplasms 10 Endometrial Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Ovarian Neoplasms 7 Glioblastoma 7 Glioma 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Breast Diseases 5 Sarcoma 4 Recurrence 4 Pancreatic Neoplasms 4 Lymphoma, Non-Hodgkin 4 Sarcoma, Ewing 3 Osteosarcoma 3 Neoplasms by Site 3 Multiple Myeloma 3 Meningioma 3 Melanoma 3 Carcinoma, Renal Cell 3 Unilateral Breast Neoplasms 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Oligodendroglioma 2

Interventions

pembrolizumab 7 Radiotherapy 3 Proton Therapy 3 Interleukin-2 3 Cyclophosphamide 3 spartalizumab 2 fludarabine 2 Rosuvastatin Calcium 2 Paclitaxel 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 Carboplatin 2 Blood Specimen Collection 2 toripalimab 1 tislelizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 osimertinib 1 niraparib 1 neotil 1 necitumumab 1 mirdametinib 1 leronlimab 1 lenvatinib 1 atezolizumab 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × abemaciclib × Clear all

NCT04092673 2024-05-21

Zotatifin

Effector Therapeutics

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡